Published online Mar 16, 2016. doi: 10.12998/wjcc.v4.i3.81
Peer-review started: August 10, 2015
First decision: October 14, 2015
Revised: November 4, 2015
Accepted: December 3, 2015
Article in press: December 4, 2015
Published online: March 16, 2016
Processing time: 216 Days and 13.7 Hours
A 60-year-old male patient presented with jaundice and dark urine for three days, icteric sclerae and skin rash on his legs for six months. Laboratory investigations revealed an atypical cryoglobulinemia with high hepatitis C virus (HCV)-RNA levels. Imaging studies showed cholestasis was accompanying HCV. Capillary zone electrophoresis using immunosubtraction method revealed a polyclonal immunoglobulin G and immunoglobulin A (IgA) monoclonal cryoglobulin and that IgA lambda was absent in immunofixation electrophoresis. After a liver biopsy, chronic hepatitis C, HCV related mixed cryoglobulinemia and cryoglobulinemic vasculitis were diagnosed and antiviral therapy was initiated. Our HCV patient presented with cryoglobulinemic symptoms with an atypical cryoglobulinemia that was detected by an alternative method: Immunosubtraction by capillary electrophoresis. Different types of cryoglobulins may therefore have a correlation with clinical symptoms and prognosis. Therefore, the accurate immunotyping of cryoglobulins with alternative methods may provide more information about cryoglobulin-generated pathology.
Core tip: We describe atypical IgA monoclonal cryoglobulinemia as the presenting symptom of chronic hepatitis C. Immunotyping of the cryoglobulin was performed with capillary zone electrophoresis with immunosubtraction method which is an alternative method to classical immunofixation electrophoresis. Accurate immunotyping of cryoglobulins with alternative method provide more information about cryoglobulin-generated pathology in atypical patients.
- Citation: Ongen B, Aksungar FB, Cicek B, Akyar I, Coskun A, Serteser M, Unsal I. Hepatitis C virus positive patient diagnosed after detection of atypical cryoglobulin. World J Clin Cases 2016; 4(3): 81-87
- URL: https://www.wjgnet.com/2307-8960/full/v4/i3/81.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v4.i3.81
Hepatitis C virus (HCV) is a single-stranded RNA virus that causes chronic liver disease since, in most affected patients, the immune system cannot completely clear the virus. Patients may develop a variety of extra-hepatic manifestations including arthritis, arthralgia, fibromyalgia, lympadenopathy and skin lesions. These various symptoms may sometimes lead to misdiagnosis and inappropriate therapies. The interaction of immune system cells and the surface proteins of HCV can cause immunological symptoms similar to those observed in autoimmune disorders. In addition, chronic immune response to HCV can produce cryoglobulins resulting in vasculitis-related skin ulcers and immune complex related nephropathy[1].
Cryoproteins are immunoglobulins in a form that precipitates in serum and plasma[2] at low temperatures. Wintrobe and Buel first described Cryoglobulinemia in 1933, and it was clinically associated with palpable purpura, arthralgia and weakness, also known as the Meltzer’s triad. Cryoproteins precipitate at temperatures below 37 °C and redissolve upon warming. They have clinical importance as they form intravascular precipitates, leading to clinical consequences such as obstruction in peripheral vessels resulting in Raynoud phenomenon, and immune-complex related vasculitis in skin, peripheral nerves and kidneys[3]. Three types of cryoglobulins have been defined depending on their immunoglobulin composition; Type I cryoglobulins are monoclonal immunoglobulins most frequently made of immunoglobulin M (IgM), followed by immunoglobulin G (IgG), and IgA. They are associated with immunoproliferative disorders like multiple myeloma and Waldenström macroglobulinemia[4]. Type II and type III cryoglobulins are polyclonal immunoglobulins, occasionally associated with monoclonal ones, that are considered to be mixed cryoglobulins[5]. Mixed cryoglobulins are associated with infectious and chronic inflammatory diseases, and constitute 90% of all types of cryoglobulins[6]. Among patients who have mixed cryoglobulinemia, 92% have HCV, 1.8% have hepatitis B virus (HBV) infection[5,6]; whereas only 5% of the patients with HCV infection show clinical signs of cryoglobulinemia[3]. Here we present a HCV positive patient with atypical cryogloblulinemia that was suspected by the discordant complete blood count (CBC) results. Immuno-typing of the cryoglobulin was carried out with capillary zone electrophoresis-immunosubtraction method (CZE/IS).
A sixty-year-old male patient presented with jaundice and dark urine that had started 3 d previously. He had had a rash on his legs for 6 mo and all examinations at that time were stated to be normal. Despite steroid therapy, there was no improvement in his rash. Physical examination revealed a BP of 120/70 mmHg, icteric sclerae and skin and there were diffuse rashes on arms and legs. An ultrasonographic scan of liver revealed cholestasis with minimal parenchymal hepatosteatosis. Laboratory investigations showed discordance in RBC, haemoglobin and haematocrit values in CBC and when blood sample tube was inspected agglutinations on the walls of the tube were remarkable (Figure 1). Upon suspicion of cryoglobulinemia, a second sample was obtained from the patient. The new sample was collected in a tube which was incubated at 37 °C and CBC was repeated after keeping it in the incubator for 20 min at 37 °C. This time results were concordant (Table 1) hence a sample was obtained at appropriate conditions in order to investigate cryoglobulins and a positive cryocrit was detected (Figure 2). Laboratory investigations yielded the following results: Serum protein electrophoresis was normal, cryoglobulins were positive, rheumatiod factor (RF) was positive, Complement 3 and 4 (C3, C4) levels were normal, anti-HCV antibody was positive, HCV RNA levels 6770728 IU/mL and HCV was type1bgenotype. Clinical Chemistry results were as follows (reference ranges are in parenthesis): Serum Urea concentration 66 mg/dL (17-49 mg/dL); Creatinine 0.97 mg/dL, (0.8-1.3 mg/dL); Total bilirubin, 3.8 mg/dL, (0.2-1.2 mg/dL); Conjugated bilirubin, 3.39 mg/dL (< 0.2 mg/dL), Alanine aminotransferase, 548 U/L (16-63U/L), Aspartate aminotransferase, 251 U/L (15-37 U/L); Gama-glutamyl transferase, 3126 U/L (15-85U/L); Total protein, 6.32 g/dL (6.4-8.3 g/dL); Albumin, 2.76 g/dL (3.5-5.0 g/dL); Prothrombin time (PT), 10.6 (10-14 s); International normalized ratio for PT, 0.96 (0.8-1.25). Pathological examination of a liver biopsy revealed a moderate cholestatic injury accompanying chronic hepatitis, and degenerative and dysplastic changes in bile ducts. The patient was diagnosed with chronic hepatitis C, HCV related mixed cryoglobulinemia and cryoglobulinemic vasculitis. Antiviral therapy, (ledipasvir and sofosbuvir-Harvoni) was initiated.
At room temperature | At 37 °C | Reference ranges | |
White blood cells | 13.93 | 15.27 | 3.8-10.0 × 103/μL |
RBC | 2.0 | 3.1 | 4.0-6.2 × 106/μL |
Hemoglobin | 12.1 | 12.6 | 13.0-17.5 g/dL |
Hematocrit | 22 | 32.5 | 40%-52% |
Mean corpuscular volume | 111.7 | 103.5 | 80-95 fL |
Mean corpuscular hemoglobin | 61.4 | 40.1 | 25-34 pg |
Mean corpuscular hemoglobin concentration | 55 | 38.8 | 31-37 g/dL |
RBC distribution width | Cannot be calculated | 17.1 | 11.2%-15% |
Platelets | 124 | 142 | 150-400 × 103/μL |
In the first sample that was obtained at room temperature, the cryoglobulins were agglutinated and may have acted as cold agglutinins, leading to the agglutination of erythrocytes, providing falsely low measurements of RBC and HCT, whereas the hemoglobin measurement was not affected since erythrocytes were hemolyzed prior to analysis.
For detection of cryoglobulins, prior to sample withdrawal, sample tube was warmed up to 37 °C, and transported to the laboratory at 37 °C. It was incubated at 37 °C until serum was separated. Separated serum was transferred to secondary tubes, and evaluation was carried out by incubating the tubes at 4 °C for seven days[4]. Tubes were inspected every day for any precipitate presence. At day 6 and 7 a precipitate was obvious and the cryocrit was measured to be 15% (Figure 2). Samples were incubated at 37 °C for 30 min and the precipitate dissolved. In order to separate cryoglobulins from other proteins in serum such as albumin, cryoprecipitate was washed with saline at 4 °C, and then it was centrifuged at 1500 rpm for five minutes at 4 °C. Supernatant was removed and saline, with the same volume of supernatant, was added. Washing was repeated for 3 times. Finally with the added saline sample it was dissolved at 37 °C[7]. Total protein and immunoglobulin concentrations in cryocrit were analyzed; immuno-typing of cryoglobulins were made using immunofixation by agarose gel electrophoresis, and CZE/IS. Absence of an albumin band in agarose gel electrophoresis indicated washing was complete. A polyclonal band at IgG heavy chain and monoclonal bands at IgM heavy chain and kappa light chain were remarkable in agarose gel electrophoresis (Figure 3). In capillary electrophoresis, albumin band was also absent, and besides polyclonal IgG and IgA gamma-globulins there was monoclonal subtraction at IgM heavy chain and kappa light chain (Figure 4). IgA lambda was absent in IFE (Figure 3). Total protein, Immunoglobulin and light chain concentrations in the cryocrit were as follows: Total protein 200 mg/dL, IgA 2.2 mg/dL, IgG 28 mg/dL, IgM 108.5 mg/dL, total kappa 31.5 mg/dL, total lamda 11.8 mg/dL.
HCV has been defined as a both heterotropic and lymphotropic virus and it may exert chronic stimulus to the immune system through different viral proteins. Chronic stimulation of the B-cells by HCV epitopes may trigger increase in some B-cell subpopulations causing the production of oligoclonal and monoclonal antibodies. Those antibodies may end up as cryoglobulins and/or cold agglutinins[8]. Only 5% of HCV patients with cryoglobulinemia have clinical symptoms. Most patients, infected with the HCV have no obvious clinical symptoms, and generally patients do not know they are infected with the virus. This was the case with our patient, too. He had no clinical symptoms other than cryoglobulinemic symptoms until development of jaundice three days previously occurring probably with the increase in cholestasis.
Healthy individuals may have cryoglobulins at low concentrations (< 0.06 g/L), which do not cause any clinical symptoms[9]; however, cryoglobulins must be investigated in presence of Raynaud phenomenon, peripheral cyanosis or ischemia, skin purpura, membranoproliferative glomerulonephritis, chronic HCV and HBV[10]. Circulating mixed cryoglobulins are much more common and their prevalence is stated to be 40%-50% in chronic HCV patients[11]. HCV related cryoglobulinemia is thought to be a result chronic antigenic stimulation of the humoral immune system however other clinical viral infections including HBV are not associated with the same high prevelance[11]. Biochemical grounds for why cryoglobulins precipitate at cold temperatures is not clearly understood. Protein sizes, concentration, hydrophobic content and strength of ionic bonds are thought to contribute; precipitating proteins are observed to have relatively greater ratio of hydrophobic amino acids and lower number of tyrosine and sialic acid residues[12]. IgM-RF-IgG complexes are thought to be an important factor for cryoprecipitation in mixed cryoglobulinemia[13]. Development of cryoaggregates can trigger vasculitis, whereas changes in chloride and calcium concentrations have been suggested as an influencing factor in kidneys and nerves, where cold exposure is not the case[14,15]. Our patient had recurrent lower extremity rash which is one of the vasculitic symptoms seen in especially type II and type III cryoglobulinemia. Although there are studies indicating the presence of bile duct abnormalities in HCV patients, a direct correlation between these abnormalities and cryoglobulinemia was not shown[16,17]. Table 2 illustrates types of cryoglobulins and laboratory findings.
Cryoglobulin type | Content | Related diseases | Laboratory findings |
Type I | Monoclonal immunoglobulins (IgG, IgM or IgA) or Bence Jones protein/monoclonal free light chains | Multiple Myeloma | Precipitation within 24 h Hyperviscosity |
Waldenstrom Macroglobulinemia | |||
Lymphoproliferative disease related monoclonal gammopathy | |||
Light chain disease | |||
Type II (mixed) | Monoclonal immunoglobulins (IgG, IgM or IgA) and polyclonal immunoglobulins (usually IgG) | HCV | Precipitation within 7 d HCV positivity Decreased C3 Decreased C4 Decreased CH50 Increased autoantibodies such as ANA, ENA, AMA |
Essential cryoglobulinemia | |||
Sjogren’s syndrome | |||
Rheumatoid arthritis | |||
Chronic lymphocytic leukemia | |||
Type III (mixed) | Polyclonal immunoglobulins | Essential cryoglobulinemia | |
Sjogren’s syndrome | |||
Systemic lupus erythematosus | |||
Viral infections (HBV, CMV, EBV, HIV) | |||
Endocarditis | |||
Biliary cirrhosis |
Sample withdrawal and transport are the most important and the critical steps for detection of cryoglobulins. Several groups have been described different analytic approaches for detection of cryoglobulins[4,10,18-20]. The main reason for false negative cryoglobulin results is incorrect withdrawal and transport procedures. United Kingdom National External Quality Assurance Scheme (UKNEQAS) organization conducted a research about detection and reporting of cryoglobulins in 137 laboratories; only in 36% of the laboratories the analysis was done without letting the temperature drop below 37 °C during serum separation, sample transport and centrifugation[7].
After washing and isolating the cryoprecipitates, cryoglobulin quantification and characterization is essential for follow up and prognosis of the patients[21]. Total protein and immunoglobulin content can be measured by nephelometry while immunotyping can be performed by immunofixation electrophoresis (IFE). CZE/IS is an alternative method to IFE for immuno-typing of monoclonal M-spike in immunoproliferative malignancies.We have used both IFE and CZE-IS methods for immunotyping of the cryoprecipitate in our patient and found out their results were slightly different. In the IFE study a polyclonal IgG and monoclonal IgM kappa bands were detected however CZE-IS study revealed a monoclonal IgM kappa and a polyclonal IgA lambda besides a polyclonal IgG content. With these findings we think we are facing an atypical mixed cryoglobulinemia, between Type II and III which may have caused cryoglobulinemic symptoms in our patient.
During IFE, specific antibodies are overlaid after electrophoresis and the corresponding immunoglobulin heavy and light chains are bound and stained. IFE is a highly sensitive and specific method to classify monoclonal immunoglobulin[22]. With the development of CZE, Immunosubtraction method is began to be used as an alternative method combined with CZE for identifying monoclonal immunoglobulins. Immunosubtraction, separates serum proteins after incubating serum with antisera for heavy and light chains, thus removing them, and detection is based on their absence when compared to serum protein electrophoresis. In CZE, the sample runs through the narrow capillary tubes and direct protein detection is performed by a measurement at 200 nm, eliminating the need for staining. We have detected especially IgA lambda by CZE/IS, which was not detected with IFE in this particular patient.
As it is previously stated only 5% of HCV patients with cryoglobulinemia have clinical symptoms[3], however, our patient had cryoglobulinemic symptoms with an atypical cryoglobulinemia. Hence, different types of cryoglobulins may have a correlation with the presentation of clinical symptoms. Although our theory must be confirmed with additional case reports we conclude that accurate immunotyping of cryoglobulins with alternative methods like CZE/IS may provide opportunities for proper management of these special patients.
A sixty-year old male patient presented with jaundice and dark urine for 3 d and rash on his legs for six months.
Jaundice and dark urine with a rash on legs for six months.
All vasculitic syndromes, viral hepatitis, autoimmune diseases.
There was a discordance in red blood cells, haemoglobin and haematocrit values in complete blood count and when blood sample tube was inspected agglutinations on the walls of the tube were remarkable. A cryocrit was positive with an atypical presentation.
An ultrasonographic scan of liver revealed cholestasis with minimal parenchymal hepatosteatosis.
Moderate cholestatic injury accompanying with chronic hepatitis, and degenerative and dysplastic changes in bile ducts revealed in liver biopsy.
Ledipasvir and sofosbuvir were initiated for hepatitis C virus (HCV) theraphy.
Chronic immune response to HCV can produce cryoglobulins resulting in vasculitis-related skin ulcers and immune complex related nephropathy. These various symptoms may sometimes lead to misdiagnosis and inappropriate therapies.
Cryoglobulinemia, cryoproteins are immunoglobulins in a form that precipitates in serum and plasma at low temperatures resulting in various vasculitic symptoms.
Different types of cryoglobulins may have a correlation with clinical symptoms and prognosis. Accurate immunotyping of cryoglobulins with alternative methods may provide more information about cryoglobulin-generated pathology.
A case report written by Ongen et al describes a unique case with HCV infection that was diagnosed by the presence of mixed cryoglobulinemia. They analyzed the characteristics of the methods for the detection of various cryoglobulins that are essential for the diagnosis of cryoglobulinemia. The case is interesting and their analysis regarding the methods for the detection of cryoglobulin such as capillary zone electrophoresis with immunosubtraction or agarose gel electrophoresis provides important information to the readers.
P- Reviewer: Shimizu Y, Tanaka N S- Editor: Qi Y L- Editor: A E- Editor: Wu HL
1. | Yang DH, Ho LJ, Lai JH. Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders. World J Gastroenterol. 2014;20:2962-2970. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis (0)] |
2. | Gorevic PD, Galanakis D. Cryoglobulins,cryofibrinogenemia and pyroglobulins. Detrick B, Ham-ilton RG, Folds JD. Manual of molecular and clinical laboratory immunology. 7th ed. Washington, D. C: ASM Press 2006; 101-111. [Cited in This Article: ] |
3. | Shihabi ZK. Cryoglobulins: an important but neglected clinical test. Ann Clin Lab Sci. 2006;36:395-408. [PubMed] [Cited in This Article: ] |
4. | Sargur R, White P, Egner W. Cryoglobulin evaluation: best practice? Ann Clin Biochem. 2010;47:8-16. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 5.0] [Reference Citation Analysis (0)] |
5. | Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest. 1993;23:399-405. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 3.6] [Reference Citation Analysis (0)] |
6. | Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355-374. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 349] [Cited by in F6Publishing: 293] [Article Influence: 14.7] [Reference Citation Analysis (0)] |
7. | Vermeersch P, Gijbels K, Mariën G, Lunn R, Egner W, White P, Bossuyt X. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem. 2008;54:39-43. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
8. | Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 180] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis (0)] |
9. | Maire MA, Mittey M, Lambert PH. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. Autoimmunity. 1989;2:155-164. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
10. | Adinolfi LE. Prevalence and incidence of cryoglobulins in chronic hepatitis C patients. Am J Gastroenterol. 2003;98:2568-2569; author reply 2569-2570. [PubMed] [Cited in This Article: ] |
11. | Schamberg NJ, Lake-Bakaar GV. Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinical Manifestations, and New Therapies. Gastroenterol Hepatol. 2007;3:695-703. [Cited in This Article: ] |
12. | Andersen BR, Tesar JT, Schmid FR, Haisty WK, Hartz WH. Biological and physical properties of a human m-cryoglobulin and its monomer subunit. Clin Exp Immunol. 1971;9:795-807. [PubMed] [Cited in This Article: ] |
13. | Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol. 2003;133:153-155. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
14. | Di Stasio E, Bizzarri P, Casato M, Galtieri A, Fiorilli M, Pucillo LP. Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation. Clin Chem Lab Med. 2004;42:614-620. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
15. | Qi M, Steiger G, Schifferli JA. A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG. J Immunol. 1992;149:2345-2351. [PubMed] [Cited in This Article: ] |
16. | Rolachon A, Pasquier D, Girard M, Arvieux J, Bichard P, Bensa JC, Zarski JP. Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C? Gastroenterol Clin Biol. 1994;18:251-256. [PubMed] [Cited in This Article: ] |
17. | Fayyazi A, Schott P, Hartmann H, Mihm S, Middel P, Ramadori G, Radzun HJ. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Z Gastroenterol. 1997;35:921-928. [PubMed] [Cited in This Article: ] |
18. | Motyckova G, Murali M. Laboratory testing for cryoglobulins. Am J Hematol. 2011;86:500-502. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis (0)] |
19. | Kallemuchikkal U, Gorevic PD. Evaluation of cryoglobulins. Arch Pathol Lab Med. 1999;123:119-125. [PubMed] [Cited in This Article: ] |
20. | Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4-13. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 242] [Cited by in F6Publishing: 211] [Article Influence: 9.6] [Reference Citation Analysis (0)] |
21. | Anis S, Abbas K, Mubarak M, Ahmed E, Bhatti S, Muzaffar R. Vasculitis with renal involvement in essential mixed cryoglobulinemia: Case report and mini-review. World J Clin Cases. 2014;2:160-166. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
22. | McCudden CR, Mathews SP, Hainsworth SA, Chapman JF, Hammett-Stabler CA, Willis MS, Grenache DG. Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins. Am J Clin Pathol. 2008;129:451-458. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis (0)] |